Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Quest Diagnostics (NY: DGX )

146.84 -0.13 (-0.09%)
Streaming Delayed Price Updated: 12:58 PM EST, Jan 27, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 368,790
Open 146.74
Bid (Size) 146.81 (1)
Ask (Size) 146.88 (2)
Prev. Close 146.97
Today's Range 145.21 - 147.33
52wk Range 120.40 - 158.34
Shares Outstanding 122,180,759
Dividend Yield 1.53%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
5 Analysts Have This to Say About Quest Diagnostics
 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For January 23, 2023
 
Via Benzinga

Performance

YTD
-5.73%
-5.73%
1 Month
-6.64%
-6.64%
3 Month
+2.94%
+2.94%
6 Month
+8.63%
+8.63%
1 Year
+8.45%
+8.45%

More News

Read More
Down 40% in 2022, Can Exact Sciences Recover in 2023?
Via The Motley Fool
Analyst Ratings for Quest Diagnostics
Via Benzinga
Where Quest Diagnostics Stands With Analysts
Via Benzinga
Golden Cross Appears Before Quest Diagnostics Investors
Via Benzinga
Where Quest Diagnostics Stands With Analysts
Via Benzinga
These 2 Defensive Plays Are Highlights Of CNBC's 'Final Trades'
Via Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For November 17, 2022
Via Benzinga
Why Quest Diagnostics Stock Jumped Today
Via The Motley Fool
Quest Diagnostics To Plunge 16%? Here Are 5 Other Price Target Changes For Thursday
Via Benzinga
DermTech and Sonora Quest Laboratories Expand Access to Innovative Melanoma Detection Test
From DermTech, Inc.
Via Business Wire
Here’s Why Quest Diagnostics Stock Should Be in Your Portfolio
Via MarketBeat
Exposures COVID-19
Quest Diagnostics Q3 Earnings Surpass Expectations, Raises Annual Guidance
Via Benzinga
Quest Diagnostics: Q3 Earnings Insights
Via Benzinga
Earnings Scheduled For October 20, 2022
Via Benzinga
A Preview Of Quest Diagnostics's Earnings
Via Benzinga
Eli Lilly, EQT, Cash Cows ETF, Northrop Grumman And This Diagnostics Company Feature On CNBC's Final Trade
Via Benzinga
What Fast Food And Entertainment Giants Did Traders Pick For CNBC's Fast Money Call Of The Day
Via Benzinga
FDA To Review Smaller Number Of Emergency Use Requests For COVID-19 Tests
Via Benzinga
COVID-19 Complacency Pushes Identification Of New Variants To Back Seat, WHO Warns
Via Benzinga
Achievers and Quest Diagnostics Win Gold in the 2022 Brandon Hall Group Excellence Technology Awards
From Achievers
Via Business Wire
Quest Becomes Exclusive Validator For Results From The Hound Cannabis Breathalyzer
Via Benzinga
No More Free COVID-19 At-Home Tests, Federal Government Says
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.